These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 33718177)
1. Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies? Deligne C; Midwood KS Front Oncol; 2021; 11():620773. PubMed ID: 33718177 [TBL] [Abstract][Full Text] [Related]
2. Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype. Deligne C; Murdamoothoo D; Gammage AN; Gschwandtner M; Erne W; Loustau T; Marzeda AM; Carapito R; Paul N; Velazquez-Quesada I; Mazzier I; Sun Z; Orend G; Midwood KS Cancer Immunol Res; 2020 Mar; 8(3):368-382. PubMed ID: 31941671 [TBL] [Abstract][Full Text] [Related]
3. The role of tumor-associated macrophage in breast cancer biology. Choi J; Gyamfi J; Jang H; Koo JS Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373 [TBL] [Abstract][Full Text] [Related]
4. The metabolic axis of macrophage and immune cell polarization. Hobson-Gutierrez SA; Carmona-Fontaine C Dis Model Mech; 2018 Jul; 11(8):. PubMed ID: 29991530 [TBL] [Abstract][Full Text] [Related]
5. Targeting Macrophages in Cancer: From Bench to Bedside. Poh AR; Ernst M Front Oncol; 2018; 8():49. PubMed ID: 29594035 [TBL] [Abstract][Full Text] [Related]
6. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells. Mierke CT Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151 [TBL] [Abstract][Full Text] [Related]
7. Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198 [TBL] [Abstract][Full Text] [Related]
8. Shaping Up the Tumor Microenvironment With Cellular Fibronectin. Efthymiou G; Saint A; Ruff M; Rekad Z; Ciais D; Van Obberghen-Schilling E Front Oncol; 2020; 10():641. PubMed ID: 32426283 [TBL] [Abstract][Full Text] [Related]
9. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment. Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032 [TBL] [Abstract][Full Text] [Related]
10. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Smirnova T; Bonapace L; MacDonald G; Kondo S; Wyckoff J; Ebersbach H; Fayard B; Doelemeyer A; Coissieux MM; Heideman MR; Bentires-Alj M; Hynes NE Oncotarget; 2016 Dec; 7(50):82289-82304. PubMed ID: 27793045 [TBL] [Abstract][Full Text] [Related]
11. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Acerbi I; Cassereau L; Dean I; Shi Q; Au A; Park C; Chen YY; Liphardt J; Hwang ES; Weaver VM Integr Biol (Camb); 2015 Oct; 7(10):1120-34. PubMed ID: 25959051 [TBL] [Abstract][Full Text] [Related]
12. Identification of tumor-associated macrophage subsets that are associated with breast cancer prognosis. Strack E; Rolfe PA; Fink AF; Bankov K; Schmid T; Solbach C; Savai R; Sha W; Pradel L; Hartmann S; Brüne B; Weigert A Clin Transl Med; 2020 Dec; 10(8):e239. PubMed ID: 33377644 [TBL] [Abstract][Full Text] [Related]
13. The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. Christensen L APMIS Suppl; 1992; 26():1-39. PubMed ID: 1576006 [TBL] [Abstract][Full Text] [Related]
14. Tenascin-C Function in Glioma: Immunomodulation and Beyond. Yalcin F; Dzaye O; Xia S Adv Exp Med Biol; 2020; 1272():149-172. PubMed ID: 32845507 [TBL] [Abstract][Full Text] [Related]
15. Human breast cancer cells educate macrophages toward the M2 activation status. Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145 [TBL] [Abstract][Full Text] [Related]
16. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers. Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467 [TBL] [Abstract][Full Text] [Related]
17. Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Ohtani H Pathol Int; 1998 Jan; 48(1):1-9. PubMed ID: 9589457 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer. Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338 [TBL] [Abstract][Full Text] [Related]
19. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [TBL] [Abstract][Full Text] [Related]
20. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages. Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]